Amlod

Quick links to important sections

Amlod

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Amlod

Quick Facts

Property Description
Active ingredient Amlodipine (typically as besylate salt)
Form Oral Tablet
Pharmacological class Dihydropyridine Calcium Channel Blocker (CCB)
Common use Antihypertensive and Anti-Anginal Agent
Origin Synthetic compound

What Type of Medicine is Amlod (Amlodipine)?

Amlod is a synthetic compound containing the single active ingredient, Amlodipine, which is classified as a Prescription-Only Medicine. Amlodipine belongs to the precise pharmacological class known as a Calcium Channel Blocker (CCB), specifically the dihydropyridine subclass. This medication is prepared for oral administration in a tablet form. Differentiation within the calcium channel blocker class is key: Amlodipine is clinically recognized for its unique long-acting profile. This extended duration of action is a distinguishing feature, allowing for a sustained effect compared to shorter-acting formulations within the same class.


What is the General Purpose of Amlodipine?

The general purpose of Amlodipine, categorized as an antihypertensive agent, is to reduce the overall strain on the cardiovascular system and promote easier blood flow. Its core action is achieved by selectively inhibiting calcium ion influx into the muscle cells of the arteries, causing the vascular smooth muscle to relax, a process known as vasodilation. The effectiveness of Amlodipine in inducing widespread peripheral vasodilation to reduce systemic pressure is a recognized clinical principle. This targeted action means the medicine helps to ease the heart's work by widening the blood vessels throughout the body. This relaxation of the arteries effectively lowers the overall peripheral vascular resistance in the body, which helps manage conditions associated with high systemic pressure, thereby supporting the function of the heart and circulatory system.

What side effects are possible with Amlod?

Possible side effects and safety information

The safety profile for Amlodipine is based on data classified by regulatory authorities according to the frequency and type of reaction experienced. Adverse reactions are systematically grouped by System-Organ-Class ( SOC), reflecting the body systems affected.


Common and Time-Related Adverse Reactions

The most frequently documented adverse reaction is oedema (swelling), specifically peripheral oedema or ankle swelling, which is classified as Very Common (ge1 out of 10 patients) in official labeling. Reactions documented as Common (ge1 out of 100 but <1 out of 10 patients) include headache, dizziness, and somnolence (drowsiness). These effects are noted in regulatory documents to be more common, particularly at the beginning of the treatment.

Other common effects involve the Cardiovascular and Gastrointestinal Systems, including palpitations, flushing, abdominal pain, and nausea.


Serious Adverse Reactions and Safety Constraints

Serious adverse events, while often classified as Very Rare (<1 out of 10,000 patients), are documented in official prescribing information. These include a noted risk of worsening angina or acute myocardial infarction following the start or increase of dosage in specific high-risk patients. Very rare reactions involving the liver include hepatitis and jaundice. Severe dermatological conditions such as Stevens-Johnson syndrome have also been reported.

Safety characteristics are noted for specific patient groups. Patients with hepatic impairment exhibit decreased clearance, and slow dose titration is recommended for those with severe impairment. Use with caution is also advised for individuals with congestive heart failure.

Overdose and Emergency Response

Amlodipine overdose is defined by the exaggerated pharmacological effect of the drug, leading primarily to profound and prolonged systemic hypotension due to massive peripheral vasodilation. This presentation may be accompanied by signs such as reflex tachycardia, dizziness, and somnolence. The recognized potential for severe outcomes, including shock and a possible fatal outcome, dictates the regulatory requirement for immediate action.

When to Seek Urgent Medical Help

Individuals must seek immediate medical attention and contact emergency services immediately upon suspicion of overdosage. Due to the drug’s long elimination half-life, an extended period of clinical observation is required in a hospital setting, necessitating active cardiac and respiratory monitoring and frequent blood pressure measurement.

Officially Described Management and Constraints

Management is strictly symptomatic and supportive, as official labeling states that no specific antidote is known. Initial interventions focus on cardiovascular support, including the use of intravenous fluids and, if hypotension is refractory, the administration of vasopressors (such as phenylephrine). The administration of intravenous calcium gluconate may be considered to counteract the effects of the calcium channel blockade. Gastrointestinal decontamination, such as administering activated charcoal, may be considered if ingestion occurred within two hours.

Therapeutic Uses of Amlod

What Amlod Treats: Main Uses and Benefits

Amlodipine is generally considered relevant for managing symptoms associated with chronic cardiovascular conditions. Its uses span several key therapeutic domains.


Sustained Management of High Blood Pressure

Amlodipine is applied when appropriate to help manage essential hypertension, a condition presenting with symptoms that relate to heightened physiological activity and systemic imbalance. Amlodipine generally supports the reduction of blood pressure, which helps to ease the overall strain on the heart and arteries. This medication may be part of symptomatic management for chronic cardiovascular disease in adults and certain pediatric groups.

Quick Fact: Relief for Elevated Pressure Focus Symptom Axis Benefit
Primary Use Arterial hypertension Supports functional stability

Relief for Angina Pectoris and Chest Discomfort

The medication is applied across therapeutic domains where additional symptomatic support is needed for Angina Pectoris, including Chronic Stable Angina and Vasospastic Angina. This approach may help to ease symptom clusters that interfere with daily comfort, as it generally supports a reduction in the frequency of anginal attacks and may assist with the patient's capacity for activity. The primary therapeutic domains include managing high blood pressure and certain forms of chest pain.

“The use of Amlodipine supports patients during difficult episodes by easing distress and may help maintain a sense of stability when symptoms are more noticeable.”

Regulatory References

  1. MedlinePlus Drug Information overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Amlod?

The official eligibility criteria for Amlodipine (Amlod) are defined by regulatory authorities and based on specific patient demographics and clinical conditions.


Contraindicated Populations (Must Not Use)

Amlodipine is contraindicated in patients with a documented hypersensitivity to the active substance or any other dihydropyridine class medicine. It must also not be used in patients experiencing conditions such as severe hypotension, cardiogenic shock, obstruction of the left ventricular outflow tract (e.g., high grade aortic stenosis), or haemodynamically unstable heart failure following a heart attack.


Age and Condition Restrictions

The medicine is approved for use in adults for both hypertension and angina. For pediatric patients, use is approved only for hypertension in children aged 6 to 17 years; use is not established in those younger than 6. Elderly patients and individuals with impaired hepatic function require conditional use with caution due to potential differences in drug clearance. Furthermore, Amlodipine is not recommended for use during pregnancy or lactation unless deemed necessary, as the drug is known to be excreted in human milk.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Documented Pharmacokinetic and Pharmacodynamic Interactions

Amlodipine’s interaction profile is documented to involve the CYP3A4 metabolic enzyme system. The co-administration of strong or moderate CYP3A4 inhibitors (e.g., certain antifungals like ketoconazole or antibiotics like clarithromycin) may result in an increase in Amlodipine's plasma concentrations, classified as a pharmacokinetic interaction. Conversely, CYP3A4 inducers (e.g., rifampicin, St. John's wort) may lead to decreased systemic exposure to Amlodipine.

Interaction Type Interacting Agent Examples
Increased Amlodipine Exposure Ketoconazole, Itraconazole, Grapefruit Juice
Increased Co-Drug Exposure Simvastatin, Cyclosporine, Tacrolimus

Interaction Restrictions and Constraints

Official regulatory information establishes specific constraints related to co-administration. Due to Amlodipine’s ability to increase the exposure of Simvastatin, the dose of Simvastatin is formally restricted to a maximum of 20 mg daily when taken concurrently. Additionally, Amlodipine may cause an additive blood pressure-lowering effect when combined with other antihypertensive agents or PDE5 inhibitors, which is classified as a pharmacodynamic interaction. Consumption of grapefruit or grapefruit juice is officially noted to potentially increase Amlodipine’s bioavailability.

Mechanism of Action

How Amlod Works

Amlodipine operates through two primary mechanistic domains to modulate cardiovascular function, focusing strictly on specific cellular and systemic pathways.


Molecular Blockade of Arterial Calcium Influx

This domain describes the initial step where Amlodipine exerts its effect by acting as a highly selective inhibitor of L-type voltage-dependent calcium channels ( Cav1.2). By physically blocking the gateway for calcium ions ( Ca^2+) into vascular smooth muscle cells, the drug interrupts the fundamental signaling sequence required for muscle contraction. The drug's unique slow association and dissociation kinetics at the receptor site is the core mechanism that contributes to its sustained duration of action.


Modulation of Systemic Vascular Resistance

The reduction in intracellular Ca^2+ concentration leads directly to the relaxation of arterial walls, resulting in widespread peripheral vasodilation. This physiological consequence is the primary factor in lowering the overall peripheral vascular resistance and the resistance against which the heart must pump (known as afterload). This mechanism extends to the coronary arteries, facilitating increased blood supply to the myocardial tissue through localized modulation of coronary vascular tone.

Dosage and Administration Information

Amlod (amlodipine) is a long-term, once-daily treatment administered orally in tablet or suspension form. The principles of its use are based on standardized dosing guidelines and mandatory scheduling patterns to ensure a consistent effect.


Administration Scope

Instruction Category Official Rule/Parameter
Route of administration Oral
Dosing schedule (Adult) Initial Dose: 5 mg once daily. Maximum Dose: 10 mg once daily
Timing in relation to meals May be taken with or without food
Age-group administration rules Older Adults and Hepatic Impairment: Initial dose of 2.5 mg once daily is suggested. Pediatric (6–17 years): Maximum dose of 5 mg once daily.
Missed-dose rules Do not double doses; skip the missed dose if it is almost time for the next scheduled dose.
Special procedural conditions Dose adjustments are generally separated by 7 to 14 days to allow the medicine to stabilize before a change.

Instruction Classifications (High-Level)

Classification Pattern/Type
Administration method type Oral
Frequency pattern Daily (Once daily)
Use-context constraints Must be taken at the same time each day.

Connection to the overall use protocol

The protocol for Amlodipine establishes a precise long-term, once-daily administration structure. This protocol dictates strict numerical dose limits and requires the dose to be taken at the same time each day to maintain consistency. Furthermore, the instructions mandate specific lower starting doses for vulnerable populations to guide the initiation of the chronic usage pattern.

Recent Clinical Evidence

Research evidence / Overview of studies for Amlod

Evidence for Use in Managing High Blood Pressure (Hypertension)

Amlodipine was studied for high blood pressure through large-scale, long-term Randomized Controlled Trials (RCTs). These extensive studies compared Amlodipine to placebo (an inactive treatment) as well as to several other common types of blood pressure medications. Researchers examined whether Amlodipine was studied for two main goals: measuring changes in blood pressure levels and observing long-term outcomes related to heart and blood vessel health.

Large long-term trials, which often spanned four to six years, monitored the occurrence of major outcomes related to systemic or functional imbalance, such as the number of strokes, heart attacks, and cardiovascular deaths across the studied groups. The data show patterns related to the incidence of these events, and the research described patterns related to strokes specifically.


Evidence for Use in Managing Chest Discomfort (Angina Pectoris)

The evidence supporting Amlodipine was studied for angina (chest discomfort) comes from randomized, controlled studies focused on symptomatic evaluation. Research explored the effect of the medicine on outcomes related to physical discomfort in adults with stable angina (exertional chest pain) and vasospastic angina (due to spasms in the heart’s arteries). These studies primarily focused on measuring changes in the frequency of anginal attacks and the corresponding use of rescue medication.

Functional studies was evaluated in stress tests, where researchers examined changes in physical activity level and the time it took for symptoms to start during exertion. These findings describe patterns for conditions characterized by fluctuating or episodic manifestations.


Evidence for Specific Patient Groups and Co-existing Conditions

For older adults, the evidence includes data from major trials where patients over 55 were frequently included, demonstrating that the medication was studied for hypertension in this group. Research has explored its use in pediatric patients (children and adolescents between the ages of 6 and 17) with high blood pressure.

Furthermore, Amlodipine was studied for managing blood pressure in adults who also have common co-existing conditions, such as diabetes mellitus and chronic kidney disease. Specific trial analyses were conducted to determine how the outcomes related to systemic or functional imbalance evolved in these higher-risk groups, and the studies monitored the pattern of long-term event occurrence in these populations.

Frequently Asked Questions (FAQ)

Common questions about Amlod (FAQ)

Q: How quickly does Amlod start to work in the body?

A: Amlod is designed for sustained, daily use. The maximum concentrations in the blood are reached between 6 and 12 hours after taking a dose. Consistent, stable drug levels are observed after approximately 7 to 8 days of consistent administration, as noted in the official prescribing information.

Q: Why is Amlod sometimes prescribed along with other blood pressure medicines?

A: Regulatory documents state Amlodipine is indicated for use alone or in combination with other blood pressure or angina medications. This combination strategy is often used because combining medicines can provide an additive blood pressure-lowering effect that supports therapeutic goals.

Q: Why does Amlod sometimes cause feelings of dizziness or lightheadedness?

A: Dizziness and lightheadedness are noted in the official product information as common side effects. These effects occur because the drug works by relaxing blood vessels and lowering blood pressure, which can sometimes result in symptomatic hypotension (a drop in pressure that causes symptoms).

Q: Does Amlod interact with common over-the-counter pain relievers or cold medicines?

A: Information indicates that a class of medications called Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), which includes many common over-the-counter pain relievers, may interact with Amlod. This interaction could potentially reduce the blood pressure-lowering effectiveness of the medicine.

Q: Does Amlod only relax blood vessels, or does it also affect heart rate?

A: Amlodipine's primary therapeutic action is relaxing blood vessels. Official studies have shown that chronic oral use is generally not associated with clinically significant alterations in the heart rate or conduction in patients.

Q: How does Amlod's effect on blood pressure differ from its effect on angina?

A: The effect is based on the same mechanism: relaxation of blood vessels (vasodilation). For high blood pressure, this relaxation occurs throughout the body to lower resistance. For angina (chest discomfort), the relaxation is targeted toward the coronary arteries, which increases blood flow and oxygen supply to the heart muscle.

Q: Is Amlod used to treat an actual angina attack, or is it for prevention?

A: Amlodipine is used to control or prevent chronic stable angina and vasospastic angina over time. Official product information notes that it is not intended to stop an acute episode of chest pain once it has already started.

Q: What happens in the body that causes swollen ankles as a side effect of Amlod?

A: Swelling, or oedema, is listed as a Very Common side effect. This is believed to be caused by Amlod's blood vessel relaxing effect, which leads to changes in pressure inside the small blood vessels (capillaries) that results in fluid accumulation in the surrounding tissues.

Q: Does Amlod affect the ability to operate machinery or drive?

A: Side effects such as dizziness, headache, or somnolence (drowsiness) are reported in the product information. Official information suggests exercising caution when driving or operating machinery if these effects are experienced.

Q: What are the signs of a non-severe allergic reaction to Amlod that patients should be aware of?

A: Non-severe signs of an allergic reaction that have been reported in clinical data include rash, itching (pruritus), and flushing. Regulatory information indicates that severe symptoms warrant contacting a healthcare provider.

Q: Why do some people experience palpitations or a racing heartbeat with Amlod?

A: Palpitations (a racing or fluttering heartbeat) have been reported as a common side effect. This may be a reflex response by the body, where the heart briefly speeds up in response to the medicine's widespread blood vessel widening effect.

Q: Does Amlod affect blood sugar levels in patients with diabetes?

A: Official adverse event reporting has associated Amlodipine with a potential increase in blood sugar levels. This condition is medically known as hyperglycemia and is listed as a reported adverse event.

Q: Are there any reported connections between Amlod and changes in mood or anxiety?

A: Nervous system side effects such as nervousness have been reported in official clinical trials. This is listed alongside other central nervous system effects.

Q: Can Amlod use be associated with muscle pain or leg cramps?

A: Musculoskeletal side effects such as muscle pain (myalgia) and muscle cramps have been reported in the official adverse reaction data.

Q: Is there information on whether Amlod can cause changes in body weight?

A: Official clinical data has reported changes in body weight as general adverse reactions. Both weight gain and weight decrease have been noted.

Q: What is the official guidance regarding the use of alcohol while taking Amlod?

A: Alcohol consumption is generally permissible, but it can potentially intensify the blood pressure-lowering effect of Amlod. This may increase the risk of experiencing side effects such as dizziness or drowsiness.

Q: What are the general warnings for stopping Amlod abruptly?

A: Regulatory information does not suggest sudden discontinuation. Official warnings note that in specific patients, particularly those with severe obstructive coronary artery disease, there is a noted risk of worsening angina or acute myocardial infarction (heart attack) following changes to the dosage.

Q: Are there any noted physical or dental side effects of Amlod like gum issues?

A: The gastrointestinal adverse reaction list includes a side effect known as gingival hyperplasia. This involves the enlargement or overgrowth of the gum tissue.

Q: What is the half-life of Amlod, meaning how long does it generally stay in the system?

A: The terminal elimination half-life is typically between 30 and 50 hours. This figure, found in clinical pharmacology data, represents the time it takes for half of the medicine to be cleared from the body.

Q: Can Amlod be linked to any potential effects on sleep patterns or insomnia?

A: Adverse effects on sleep have been reported in clinical data. These include both somnolence (drowsiness) and the opposite effect, difficulty sleeping (insomnia).

Q: Is Amlod described as safe to take with calcium supplements?

A: Interaction information emphasizes that using Amlodipine with calcium salts, such as calcium carbonate supplements, may potentially decrease Amlodipine's overall effectiveness.

Q: Does Amlod cause symptoms that can feel like a common cold or sinus issue?

A: Adverse reactions reported have included symptoms related to the respiratory tract. These symptoms include cough, pharyngitis (sore throat), and sinusitis.

Q: What are the noted differences in side effect profiles between the 5mg and 10mg strengths of Amlod?

A: Clinical trial data has shown that the incidence of certain side effects may vary by dose. For instance, the occurrence of oedema (swelling) may be higher with the 10 mg daily dose compared to the 5 mg daily dose.

How should Amlod be stored and disposed of?

Amlodipine tablets must be stored at a defined Controlled Room Temperature, which is 20 C to 25 C (68 F to 77 F), with permitted excursions between 15 C and 30 C (59 F and 86 F). Storage must be maintained below 30 C.

To ensure product stability, the tablets require protection from light and must be kept in the original container. The medication must be securely stored out of the sight and reach of children to prevent accidental ingestion.

Disposal

Any unused or expired amlodipine product or related waste material must be disposed of in accordance with local requirements. This regulatory instruction ensures environmentally sound handling and disposal procedures are followed.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Amlod found in:

A-Z Index: